NY State Senate Bill 2015-S5583

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 06, 2016	referred to health
May 15, 2015	referred to health

2015-S5583 (ACTIVE) - Details

Current Committee:: Senate Health
Law Section:: Public Health Law
Laws Affected:: Amd §2500-a, Pub Health L
Versions Introduced in Other Legislative Sessions:: 2017-2018: S520
2019-2020: S990

2015-S5583 (ACTIVE) - Summary

Directs physicians to screen newborns for neonatal abstinence syndrome.

2015-S5583 (ACTIVE) - Sponsor Memo

                                BILL NUMBER:S5583

TITLE OF BILL:

An act to amend the public health law, in relation to requiring facili-
ties to screen newborns for neonatal abstinence syndrome through toxico-
logical screening of infants' meconium or urine

PURPOSE:

This bill would require healthcare facilities to screen newborns for
neonatal abstinence syndrome, which results from a fetus being exposed
to opiates or narcotics while in the womb, through toxicological screen-
ing.

JUSTIFICATION:

Neonatal Abstinence Syndrome (NAS) is a group of symptoms that occur in
a newborn who was exposed to prescription or addictive illegal drugs
while in the mother's womb during pregnancy. Newborns have an alarmingly
high rate of testing positive for NAS as a result of high rates of
addiction to narcotics and other drugs in many regions of New York
State. It is in the public interest to address this public health
crisis.

The number of newborns that are diagnosed with NAS has increased each

year between 2010 and 2012, a rate of 83.8 per 10,000 births. In Western
New York, the birthrate for babies born with a drug-related diagnosis is
more than twice the statewide average. Per 10,000 babies born, there are
179 diagnosed with drug related symptoms in Western New York, the high-
est rate in the state.

This bill would help lessen negative health outcomes for newborns by
requiring a standardized statewide method for healthcare facilities to
test for NAS in newborns. In some instances, newborns may not exhibit
signs or symptoms until a week or two after birth. Requiring that
newborns be tested would allow health care professionals to respond
quickly and appropriately to positive test results.

LEGISLATIVE HISTORY:

New Bill.

FISCAL IMPLICATIONS:

To be determined.

EFFECTIVE DATE:

This act shall take effect on the one hundred eightieth day after it
shall have become a law; provided, however, that effective immediately,
the addition, amendment and/or repeal of any rule or regulation neces-

sary for the implementation of this act on its effective date are
authorized and directed to be made and completed on or before such
effective date.

2015-S5583 (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5583

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                              May 15, 2015
                               ___________

Introduced  by  Sen.  YOUNG  -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to requiring  facili-
  ties to screen newborns for neonatal abstinence syndrome through toxi-
  cological screening of infants' meconium or urine

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Legislative  intent.  The  legislature  hereby  finds  that
neonatal  abstinence  syndrome (NAS) is a public health crisis affecting
all levels of society in New York state.  Newborns  have  an  alarmingly
high  rate  of  testing  positive  for  NAS as a result of high rates of
addiction to narcotics and other drugs in many  regions  of  the  state.
Addressing this public health crisis serves the public interest by help-
ing  to ensure that newborns in this state receive appropriate treatment
as early as possible to prevent adverse health outcomes.
  Between 2010 and 2012, there were 5,857 newborn drug-related diagnoses
in this state, a rate of 83.8 diagnoses per 10,000 births.  In  each  of
those  years,  the  number  of  newborns  diagnosed  with a drug-related
illness increased. In the United States,  between  2000  and  2009,  the
number  of newborns reported to have neonatal abstinence syndrome nearly
tripled.  This is indicative of a public  health  crisis  affecting  all
regions of the state and nation.
  Current  methods  for detecting NAS are inadequate, relying heavily on
newborn observation and questioning of the mother  regarding  opiate  or
narcotic  use.  In many instances, newborns are taken home after twenty-
four to forty-eight hours. This time period may be inadequate for obser-
vation to detect NAS symptoms.  Toxicological  testing  of  a  newborn's
meconium or urine allows hospitals to detect NAS early, thereby enabling
such  facilities  to  begin  treatment  to prevent future adverse health
outcomes.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11191-01-5

S. 5583                             2

  S 2. Subdivision (a) of section 2500-a of the public  health  law,  as
amended  by  chapter  184  of  the  laws  of 2013, is amended to read as
follows:
  (a) It shall be the duty of the administrative officer or other person
in  charge  of  each institution caring for infants twenty-eight days or
less of age and the person required in pursuance of  the  provisions  of
section  forty-one  hundred thirty of this chapter to register the birth
of a child, to cause to have administered to every such infant or  child
in  its  or  his care a test for phenylketonuria, homozygous sickle cell
disease, hypothyroidism, branched-chain ketonuria,  galactosemia,  homo-
cystinuria,  critical  congenital  heart  defects through pulse oximetry
screening, NEONATAL ABSTINENCE SYNDROME, and  such  other  diseases  and
conditions as may from time to time be designated by the commissioner in
accordance  with  rules  or  regulations prescribed by the commissioner.
Testing, the recording of the results of such tests, tracking, follow-up
reviews and educational activities shall be performed at such times  and
in such manner as may be prescribed by the commissioner. The commission-
er shall promulgate regulations setting forth the manner in which infor-
mation describing the purposes of the requirements of this section shall
be disseminated to parents or a guardian of the infant tested.
  S 3. This act shall take effect on the one hundred eightieth day after
it shall have become a law; provided, however, that effective immediate-
ly,  the  addition,  amendment  and/or  repeal of any rule or regulation
necessary for the implementation of this act on its  effective  date  is
authorized  and  directed  to  be  made  and completed on or before such
effective date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S5583

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee

2015-S5583 (ACTIVE) - Details

2015-S5583 (ACTIVE) - Summary

2015-S5583 (ACTIVE) - Sponsor Memo

2015-S5583 (ACTIVE) - Bill Text download pdf

Comments

Senate Bill S5583

Share this bill

Sponsored By

Catharine Young

Archive: Last Bill Status - In Senate Committee Health Committee

2015-S5583 (ACTIVE) - Details

2015-S5583 (ACTIVE) - Summary

2015-S5583 (ACTIVE) - Sponsor Memo

2015-S5583 (ACTIVE) - Bill Text download pdf

Comments